首页> 美国卫生研究院文献>Gut Pathogens >Antimicrobial resistant Helicobacter fennelliae isolated from non-diarrheal child stool sample in Battambang Cambodia
【2h】

Antimicrobial resistant Helicobacter fennelliae isolated from non-diarrheal child stool sample in Battambang Cambodia

机译:从柬埔寨马德望的非腹泻儿童粪便样本中分离出具有抗药性的幽门螺杆菌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Helicobacter fennelliae (H. fennelliae) is associated with human gastroenteritis; however, H. fennelliae was isolated and confirmed by phenotypic and genotypic identification from a non-diarrheal child stool sample in Cambodia. Antimicrobial susceptibility testing demonstrated that this isolate had a high minimal inhibitory concentration against macrolides and quinolones, which are first-line antibiotic treatment choices for Campylobacter infections. Consequently, macrolides and quinolones were likewise expected to be ineffective against Campylobacter-like organisms such as H. fennelliae. This isolate warranted further genetic characterization to better understand associated antibiotic resistance mechanisms. Resistant pathogens from asymptomatic diarrheal cases are likely underestimated, and as such colonized individuals may spread resistant organisms to local community members and the environment.
机译:幽门螺杆菌(H. fennelliae)与人类胃肠炎有关。然而,从柬埔寨的非腹泻儿童粪便样本中分离并通过表型和基因型鉴定证实了H. fennelliae。抗菌药敏试验表明,这种分离物对大环内酯类和喹诺酮类药物具有较高的最低抑菌浓度,而大环内酯类和喹诺酮类药物是弯曲杆菌感染的一线抗生素治疗选择。因此,也预期大环内酯类和喹诺酮类药物对弯曲杆菌样生物如H. fennelliae无效。该分离株需要进一步的遗传学表征,以更好地了解相关的抗生素抗性机制。来自无症状腹泻病例的抗药性病原体可能被低估了,因为这种定殖的个体可能会将抗药性生物传播到当地社区成员和环境中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号